etanercept products — Medica

Initial criteria

• age ≥ 4 years
• Patient has tried at least one traditional systemic agent for psoriasis for at least 3 months unless intolerant OR Patient has a contraindication to methotrexate, as determined by the prescriber
• Medication is prescribed by or in consultation with a dermatologist

Reauthorization criteria

• Patient has been established on therapy for at least 3 months
• Patient experienced a beneficial clinical response from baseline in at least one of the following: estimated body surface area, erythema, induration/thickness, and/or scale of areas affected by psoriasis
• Compared with baseline, patient experienced improvement in at least one symptom, such as decreased pain, itching, and/or burning

Approval duration

3 months initial, 1 year reauth